Regeneron Predicts Impending Biosimilar Lucentis Impact On Eylea Brand

Samsung Bioepis Tipped For US Ranibizumab Biosimilar Approval Soon

 
• By Dean Rudge
  
Eye
Biosimilar ranibizumab is due to launch in the US later this year • Source: Shutterstock
Generics Bulletin Podcast

Stay ahead of every shift in generics and biosimilars.

Generics Bulletin brings you the latest updates that matter for the off-patent industry.

SpotifyApple PodcastsWebsite

More from Biosimilars

More from Products